5AM Partners VII, LLC

13D and 13G Filings

13D/G filings: 13D on 2 securities, 13G on 1 security
CIK: 0001873545
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Skye Bioscience, Inc. 13D/A Amendment 6 SKYE · 83086J309	SKYE	83086J309	26.1%	1,218,088	13D/A Amendment 6	9/24/2026 Event 9/22/2026
5AM Partners VII, LLC			25.7%	1,194,443
5AM Ventures VII, L.P.			25.7%	1,194,443
5AM Partners II, LLC			0%	0
5AM Ventures II, L.P.			0%	0
5AM Co-Investors II, L.P.			0%	0
Andrew J. Schwab			26.1%	1,218,088
Kush Parmar			25.7%	1,194,443
John D. Diekman			0%	0
Scott M. Rocklage			0%	0
Skye Bioscience, Inc. 13D/A Amendment 5 SKYE · 83086J200	SKYE	83086J200	30.2%	11,273,407	13D/A Amendment 5	8/18/2026 Event 8/14/2026
5AM Partners VII, LLC			25.9%	9,619,519
5AM Ventures VII, L.P.			25.9%	9,619,519
5AM Partners II, LLC			4.1%	1,467,637
5AM Ventures II, L.P.			4.0%	1,411,974
5AM Co-Investors II, L.P.			0.2%	55,663
Andrew J. Schwab			30.2%	11,273,407
Kush Parmar			25.9%	9,619,519
John D. Diekman			4.1%	1,467,637
Scott M. Rocklage			4.1%	1,467,637
Surrozen, Inc. 13G/A Amendment 2 SRZN · 86889P208	SRZN	86889P208	7.8%	968,750	13G/A Amendment 2	8/11/2026 Event 6/30/2026
5AM Partners VII, LLC			7.8%	968,750
5AM Ventures VII, L.P.			7.8%	968,750
Kush Parmar			7.8%	968,750
Andrew J. Schwab			7.8%	968,750
Surrozen, Inc. 13G/A Amendment 1 SRZN · 86889P208	SRZN	86889P208	9.5%	1,162,500	13G/A Amendment 1	5/15/2026 Event 3/31/2026
5AM Partners VII, LLC			9.5%	1,162,500
5AM Ventures VII, L.P.			9.5%	1,162,500
Kush Parmar			9.5%	1,162,500
Andrew J. Schwab			9.5%	1,162,500
Skye Bioscience, Inc. 13D/A Amendment 4 SKYE · 83086J200	SKYE	83086J200	34.0%	11,541,317	13D/A Amendment 4	12/16/2025 Event 12/12/2025
5AM Partners VII, LLC			29.2%	9,872,599
5AM Ventures VII, L.P.			29.2%	9,872,599
5AM Partners II, LLC			4.7%	1,514,557
5AM Ventures II, L.P.			4.5%	1,457,064
5AM Co-Investors II, L.P.			0.2%	57,493
Andrew J. Schwab			34.0%	11,541,317
Kush Parmar			29.2%	9,872,599
John D. Diekman			4.7%	1,514,557
Scott M. Rocklage			4.7%	1,514,557
Surrozen, Inc. 13G SRZN · 86889P208	SRZN	86889P208	9.9%	908,387	13G	4/2/2025 Event 3/26/2025
5AM Partners VII, LLC			9.9%	908,387
5AM Ventures VII, L.P.			9.9%	908,387
Kush Parmar			9.9%	908,387
Andrew J. Schwab			9.9%	908,387
Skye Bioscience, Inc. 13D/A Amendment 3 SKYE · 83086J200	SKYE	83086J200	36.4%	11,696,895	13D/A Amendment 3	12/19/2024 Event 12/17/2024
5AM Partners VII, LLC			30.8%	9,872,599
5AM Ventures VII, L.P.			30.8%	9,872,599
5AM Partners II, LLC			5.8%	1,745,962
5AM Ventures II, L.P.			5.5%	1,679,685
5AM Co-Investors II, L.P.			0.2%	66,277
Andrew J. Schwab			36.4%	11,696,895
Kush Parmar			30.8%	9,872,599
John D. Diekman			5.8%	1,745,962
Scott M. Rocklage			5.8%	1,745,962

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.